Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VetCBD is a veterinary-founded company specializing in cannabinoid-based products designed specifically for animal health. Founded in 2015 by Dr. Tim Shu, a veterinarian, the company focuses on providing medical-grade CBD formulations to help pets manage conditions such as pain, anxiety, inflammation, and seizures. Their product line includes full-spectrum hemp-derived tinctures available nationwide and cannabis-derived formulations distributed through licensed dispensaries in California. VetCBD distinguishes itself through a commitment to veterinary-led education, rigorous third-party lab testing, and precise dosing protocols tailored for various species. The company's mission is to improve the quality of life for animals through safe and effective cannabinoid therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vet CBD.